These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8251610)

  • 1. Intravenous verapamil kinetics in rats: marked arteriovenous concentration difference and comparison with humans.
    Manitpisitkul P; Chiou WL
    Biopharm Drug Dispos; 1993 Oct; 14(7):555-66. PubMed ID: 8251610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PBPK modeling to unravel nonlinear pharmacokinetics of verapamil to estimate the fractional clearance for verapamil N-demethylation in the recirculating rat liver preparation.
    Yang QJ; Si L; Tang H; Sveigaard HH; Chow EC; Pang KS
    Drug Metab Dispos; 2015 Apr; 43(4):631-45. PubMed ID: 25650380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological pharmacokinetics and pharmacodynamics of (+/-)-verapamil in female rats.
    Todd EL; Abernethy DR
    Biopharm Drug Dispos; 1987; 8(3):285-97. PubMed ID: 3593905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of atorvastatin on the intravenous and oral pharmacokinetics of verapamil in rats.
    Choi DH; Chang KS; Hong SP; Choi JS; Han HK
    Biopharm Drug Dispos; 2008 Jan; 29(1):45-50. PubMed ID: 17941000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of early phase adjuvant arthritis on hepatic P450 enzymes and pharmacokinetics of verapamil: an alternative approach to the use of an animal model of inflammation for pharmacokinetic studies.
    Ling S; Jamali F
    Drug Metab Dispos; 2005 Apr; 33(4):579-86. PubMed ID: 15659540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of cimetidine on the pharmacokinetics of the enantiomers of verapamil in the dog during multiple oral dosing.
    Johnson LM; Lankford SM; Bai SA
    J Vet Pharmacol Ther; 1995 Apr; 18(2):117-23. PubMed ID: 7629925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of lidocaine on plasma protein binding and pharmacokinetics of verapamil in dogs.
    Belpaire FM; De Rick A; De Smet F; Bourda A; Rosseel MT; Bogaert MG
    Prog Clin Biol Res; 1989; 300():437-40. PubMed ID: 2780641
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of the enantiomers of verapamil in the dog.
    Bai SA; Lankford SM; Johnson LM
    Chirality; 1993; 5(6):436-42. PubMed ID: 8398603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of verapamil and its metabolite norverapamil in rats with hyperlipidaemia induced by poloxamer 407.
    Lee YS; Yoon JN; Yoon IS; Lee MG; Kang HE
    Xenobiotica; 2012 Aug; 42(8):766-74. PubMed ID: 22300394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantioselective distribution of verapamil and norverapamil into human and rat erythrocytes: the role of plasma protein binding.
    Robinson MA; Mehvar R
    Biopharm Drug Dispos; 1996 Oct; 17(7):577-87. PubMed ID: 8894116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified reversed-phase HPLC method with spectrophotometric detection for the assay of verapamil in rat plasma.
    Lau-Cam CA; Piemontese D
    J Pharm Biomed Anal; 1998 Feb; 16(6):1029-35. PubMed ID: 9547706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics and pharmacodynamics of d- and dl-verapamil in rabbits.
    Giacomini JC; Nelson WL; Theodore L; Wong FM; Rood D; Giacomini KM
    J Cardiovasc Pharmacol; 1985; 7(3):469-75. PubMed ID: 2410676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced bioavailability of verapamil after oral administration with hesperidin in rats.
    Piao YJ; Choi JS
    Arch Pharm Res; 2008 Apr; 31(4):518-22. PubMed ID: 18449511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration.
    Eichelbaum M; Mikus G; Vogelgesang B
    Br J Clin Pharmacol; 1984 Apr; 17(4):453-8. PubMed ID: 6721991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of lignocaine on plasma protein binding and pharmacokinetics of verapamil in dogs.
    Belpaire FM; De Rick A; Bourda A; De Smet F; Rosseel MT; Bogaert MG
    J Pharm Pharmacol; 1990 Jan; 42(1):45-9. PubMed ID: 1969949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of gender on the pharmacokinetics of verapamil and norverapamil in human.
    Dadashzadeh S; Javadian B; Sadeghian S
    Biopharm Drug Dispos; 2006 Oct; 27(7):329-34. PubMed ID: 16892180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic behavior and tissue distribution of verapamil and its enantiomers in rats by HPLC.
    He L; Wang S
    Arch Pharm Res; 2003 Sep; 26(9):763-7. PubMed ID: 14560927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased binding of verapamil to plasma proteins in patients with liver disease.
    Giacomini KM; Massoud N; Wong FM; Giacomini JC
    J Cardiovasc Pharmacol; 1984; 6(5):924-8. PubMed ID: 6209501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat.
    Frantz SW; Beskitt JL; Tallant MJ; Zourelias LA; Ballantyne B
    Xenobiotica; 1996 May; 26(5):515-39. PubMed ID: 8736063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of infliximab on hepatic cytochrome P450 and pharmacokinetics of verapamil in rats with pre-adjuvant arthritis: a drug-disease and drug-drug interaction.
    Ling S; Jamali F
    Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):24-9. PubMed ID: 19371259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.